| SS/JrHsdMcwi |
ratio of change in renal blood flow rate to kidney weight |
controlled sodium content diet (0.4 %) (for 16 hours) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renal blood flow trait |
female |
97.0 days-101.0 days |
13 |
|
|
-2.4 |
ml/min/g |
0.5 |
1.8 |
electromagnetic flowmetry |
|
0.0 |
|
electromagnetic flowmetry |
|
67306 |
151 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
|
54.0 |
% |
2.2 |
4.92 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
69578 |
732 |
| SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
4 |
TA/BW |
|
1.68 |
mg/g |
0.04 |
0.08 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99051 |
2198 |
| SS/JrHsdMcwi |
extensor digitorum longus muscle weight to body weight ratio |
control condition (for 7 days) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
3 |
EDL/BW |
|
0.43 |
mg/g |
0.01 |
0.02 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99053 |
2198 |
| SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
4 |
TA/BW |
|
1.74 |
mg/g |
0.08 |
0.16 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99052 |
2198 |
| SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
3 |
TA/BW |
|
1.88 |
mg/g |
0.04 |
0.07 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99056 |
2198 |
| SS/JrHsdMcwi |
heart left ventricle end-diastolic anterior wall thickness |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle anterior wall thickness |
male |
63.0 days-70.0 days |
5 |
|
|
2.19 |
mm |
0.21 |
0.47 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105810 |
3023 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
|
serial mean |
131.3 |
mmHg |
4.2 |
15.14 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69530 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
|
serial mean |
160.2 |
mmHg |
3.5 |
12.62 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69534 |
151 |
| SS/JrHsdMcwi |
heart left ventricle end-diastolic anterior wall thickness |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle anterior wall thickness |
male |
77.0 days-84.0 days |
5 |
|
|
2.13 |
mm |
0.09 |
0.2 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105812 |
3023 |
| SS/JrHsdMcwi |
heart left ventricle end-diastolic posterior wall thickness |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle posterior wall thickness |
male |
63.0 days-70.0 days |
5 |
|
|
2.17 |
mm |
0.11 |
0.25 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105816 |
3023 |
| SS/JrHsdMcwi |
heart left ventricle end-diastolic diameter |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
63.0 days-70.0 days |
5 |
|
|
6.63 |
mm |
0.37 |
0.83 |
transthoracic echocardiography |
|
0.0 |
|
|
should be inner diameter |
105822 |
3023 |
| SS/JrHsdMcwi |
heart rate |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart pumping trait |
male |
63.0 days-70.0 days |
5 |
|
|
394.0 |
beats/min |
6.0 |
13.42 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105834 |
3023 |
| SS/JrHsdMcwi |
cardiac output |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
cardiac output trait |
male |
63.0 days-70.0 days |
5 |
|
|
78.0 |
ml/min |
10.0 |
22.36 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105846 |
3023 |
| SS/JrHsdMcwi |
lung weight to tibia length ratio |
angiotensin II (200 ng/kg/min) (for 28 days) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
lung mass |
male |
77.0 days-84.0 days |
6 |
|
|
0.28 |
g/cm |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
105854 |
3023 |
| SS/JrHsdMcwi |
single kidney weight to tibia length ratio |
angiotensin II (200 ng/kg/min) (for 28 days) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
kidney mass |
male |
77.0 days-84.0 days |
6 |
|
|
0.28 |
g/cm |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
105852 |
3023 |
| SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
3 |
TA/BW |
|
1.77 |
mg/g |
0.05 |
0.09 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99055 |
2198 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
|
|
247.0 |
um |
7.8 |
17.44 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
69574 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
|
|
246.0 |
um |
3.7 |
8.27 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
69577 |
732 |
| SS/JrHsdMcwi |
body weight |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
56.0 days-70.0 days |
4 |
|
|
270.8 |
g |
7.8 |
15.6 |
body weighing method |
|
0.0 |
|
|
|
99014 |
2198 |
| SS/JrHsdMcwi |
body weight |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
56.0 days-70.0 days |
3 |
|
|
282.8 |
g |
2.9 |
5.02 |
body weighing method |
|
0.0 |
|
|
|
99016 |
2198 |
| SS/JrHsdMcwi |
extensor digitorum longus muscle weight to body weight ratio |
control condition (for 7 days) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
4 |
EDL/BW |
|
0.4 |
mg/g |
0.02 |
0.04 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99049 |
2198 |
| SS/JrHsdMcwi |
heart left ventricle fractional shortening |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
63.0 days-70.0 days |
5 |
|
|
57.2 |
% |
2.7 |
6.04 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105828 |
3023 |
| SS/JrHsdMcwi |
stroke volume |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
63.0 days-70.0 days |
5 |
|
|
0.2 |
ml |
0.03 |
0.06 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105840 |
3023 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
6 |
|
|
157.0 |
um |
2.0 |
4.9 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
69573 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
|
37.0 |
% |
1.5 |
3.35 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
69575 |
732 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
|
serial mean |
147.2 |
mmHg |
3.9 |
14.06 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
69532 |
151 |
| SS/JrHsdMcwi |
extensor digitorum longus muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
4 |
EDL/BW |
|
0.41 |
mg/g |
0.02 |
0.04 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99050 |
2198 |
| SS/JrHsdMcwi |
extensor digitorum longus muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
3 |
EDL/BW |
|
0.46 |
mg/g |
0.01 |
0.02 |
ex vivo method |
|
0.0 |
|
|
TA or EDL muscle weight body weight ratio |
99054 |
2198 |
| SS/JrHsdMcwi |
heart left ventricle end-diastolic posterior wall thickness |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle posterior wall thickness |
male |
77.0 days-84.0 days |
5 |
|
|
1.94 |
mm |
0.18 |
0.4 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105818 |
3023 |
| SS/JrHsdMcwi |
heart left ventricle end-diastolic diameter |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
77.0 days-84.0 days |
5 |
|
|
7.15 |
mm |
0.34 |
0.76 |
transthoracic echocardiography |
|
0.0 |
|
|
should be inner diameter |
105824 |
3023 |
| SS/JrHsdMcwi |
cardiac output |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
cardiac output trait |
male |
77.0 days-84.0 days |
5 |
|
|
77.0 |
ml/min |
6.0 |
13.42 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105848 |
3023 |
| SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
13 |
|
serial mean |
34.0 |
mmHg |
3.0 |
10.82 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
67300 |
151 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
|
|
113.0 |
um |
4.2 |
9.39 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
69576 |
732 |
| SS/JrHsdMcwi |
heart left ventricle fractional shortening |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
77.0 days-84.0 days |
5 |
|
|
51.9 |
% |
3.7 |
8.27 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105830 |
3023 |
| SS/JrHsdMcwi |
heart rate |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart pumping trait |
male |
77.0 days-84.0 days |
5 |
|
|
358.0 |
beats/min |
17.0 |
38.01 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105836 |
3023 |
| SS/JrHsdMcwi |
stroke volume |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
77.0 days-84.0 days |
5 |
|
|
0.22 |
ml |
0.02 |
0.05 |
transthoracic echocardiography |
|
0.0 |
|
|
|
105842 |
3023 |
| SS/JrHsdMcwi |
heart left ventricle weight to tibia length ratio |
angiotensin II (200 ng/kg/min) (for 28 days) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle mass |
male |
77.0 days-84.0 days |
6 |
|
|
0.19 |
g/cm |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
105850 |
3023 |
| SS/JrHsdMcwi |
tibia length |
angiotensin II (200 ng/kg/min) (for 28 days) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
tibia length |
male |
77.0 days-84.0 days |
6 |
|
|
3.96 |
cm |
0.03 |
0.07 |
post excision length measurement |
|
0.0 |
|
|
|
105856 |
3023 |